128 related articles for article (PubMed ID: 3858789)
1. Anaphylaxis to L-asparaginase during treatment for acute lymphoblastic leukemia in children--evidence of a complement-mediated mechanism.
Fabry U; Körholz D; Jürgens H; Göbel U; Wahn V
Pediatr Res; 1985 Apr; 19(4):400-8. PubMed ID: 3858789
[TBL] [Abstract][Full Text] [Related]
2. [Formation of specific IgG antibodies in l-asparaginase treatment. Distribution of IgG subclasses].
Körholz D; Urbanek R; Nürnberger W; Jobke A; Göbel U; Wahn V
Monatsschr Kinderheilkd; 1987 Jun; 135(6):325-8. PubMed ID: 3475571
[TBL] [Abstract][Full Text] [Related]
3. Antibody response to Escherichia coli L-asparaginase. Prognostic significance and clinical utility of antibody measurement.
Cheung NK; Chau IY; Coccia PF
Am J Pediatr Hematol Oncol; 1986; 8(2):99-104. PubMed ID: 3526939
[TBL] [Abstract][Full Text] [Related]
4. Dynamic changes in specific anti-L-asparaginase antibodies generation during acute lymphoblastic leukemia treatment.
Walenciak J; Wyka K; Janczar S; Młynarski W; Zalewska-Szewczyk B
Pharmacol Rep; 2019 Apr; 71(2):311-318. PubMed ID: 30826572
[TBL] [Abstract][Full Text] [Related]
5. Modified pharmacokinetics of I-asparaginase from E coli by formation of specific antibodies to I-Asparaginase of different immunoglobulin classes in children with acute lymphocytic leukemia.
Wahn V; Fabry U; Körholz D; Reinhardt D; Jürgens H; Göbel U
Pediatr Pharmacol (New York); 1983; 3(3-4):303-11. PubMed ID: 6377216
[TBL] [Abstract][Full Text] [Related]
6. Immunological aspects of L-asparaginase treatment in children with lymphoproliferative disease.
Zajaczkowski J; Pituch A; Legutko L; Pajak E
Helv Paediatr Acta; 1976 Jan; 30(4-5):441-6. PubMed ID: 1060605
[TBL] [Abstract][Full Text] [Related]
7. [Allergic reactions in treatment with L-asparaginase. Significance of specific IgE antibodies].
Körholz D; Wahn U; Jürgens H; Wahn V
Monatsschr Kinderheilkd; 1990 Jan; 138(1):23-5. PubMed ID: 2314401
[TBL] [Abstract][Full Text] [Related]
8. [Immunological aspects in the L-asparaginase treatment of children with lymphoproliferative diseases].
Zajaçzkowski J; Halikowski B; Pituch A; Legutko L; Pajdak E
Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(1):21-8. PubMed ID: 58815
[TBL] [Abstract][Full Text] [Related]
9. Comparison of anaphylactic reactions to asparaginase derived from Escherichia coli and from Erwinia cultures.
Dellinger CT; Miale TD
Cancer; 1976 Oct; 38(4):1843-6. PubMed ID: 791476
[TBL] [Abstract][Full Text] [Related]
10. L-asparaginase-induced hypocomplementemia in acute lymphocytic leukemia (ALL) of childhood.
Shapiro R; Kim Y; Michael AF; Gerrard JM; Nesbit M; Coccia P; Ramsay NK; Krivit W
Am J Pediatr Hematol Oncol; 1979; 1(1):5-7. PubMed ID: 295575
[TBL] [Abstract][Full Text] [Related]
11. Immunological responses to L-asparaginase.
Peterson RG; Handschumacher RE; Mitchell MS
J Clin Invest; 1971 May; 50(5):1080-90. PubMed ID: 4101590
[TBL] [Abstract][Full Text] [Related]
12. Anaphylactic reaction to polyethylene-glycol conjugated-asparaginase: premedication and desensitization may not be sufficient.
Sahiner UM; Yavuz ST; Gökce M; Buyuktiryaki B; Altan I; Aytac S; Tuncer M; Tuncer A; Sackesen C
Pediatr Int; 2013 Aug; 55(4):531-3. PubMed ID: 23910807
[TBL] [Abstract][Full Text] [Related]
13. PEG-asparaginase allergy in children with acute lymphoblastic leukemia in the NOPHO ALL2008 protocol.
Henriksen LT; Harila-Saari A; Ruud E; Abrahamsson J; Pruunsild K; Vaitkeviciene G; Jónsson ÓG; Schmiegelow K; Heyman M; Schrøder H; Albertsen BK;
Pediatr Blood Cancer; 2015 Mar; 62(3):427-33. PubMed ID: 25418987
[TBL] [Abstract][Full Text] [Related]
14. L-asparaginase activity and anti-L-asparaginase antibody as biomarkers in estimating PEG-asp-related anaphylaxis risk in childhood acute lymphoblastic leukemia patients.
Cui J; Jiang L; Xu B; Bai Y
Allergol Immunopathol (Madr); 2023; 51(3):28-35. PubMed ID: 37169557
[TBL] [Abstract][Full Text] [Related]
15. Therapy with Erwinia L-asparaginase in children with acute leukemia after anaphylaxis to E. coli L-asparaginase.
King OY; Wilbur JR; Mumford DM; Sutow WW
Cancer; 1974 Mar; 33(3):611-4. PubMed ID: 4592901
[No Abstract] [Full Text] [Related]
16. [The role of anti L-asparaginase antibody in childhood acute lymphoblastic leukemia].
Akazai A; Oda M; Nishiuchi R; Horiuchi T; Henmi M; Manki A; Seino Y
Rinsho Ketsueki; 1996 Feb; 37(2):95-100. PubMed ID: 8852025
[TBL] [Abstract][Full Text] [Related]
17. Development of anti-asparaginase antibodies in childhood acute lymphoblastic leukemia.
Zalewska-Szewczyk B; Andrzejewski W; Bodalski J
Pediatr Blood Cancer; 2004 Oct; 43(5):600-2. PubMed ID: 15382279
[TBL] [Abstract][Full Text] [Related]
18. Alternative algorithm for L-asparaginase allergy in children with acute lymphoblastic leukemia.
Soyer OU; Aytac S; Tuncer A; Cetin M; Yetgin S; Sekerel BE
J Allergy Clin Immunol; 2009 Apr; 123(4):895-9. PubMed ID: 19081614
[TBL] [Abstract][Full Text] [Related]
19. Use of L-asparaginase and cytosine arabinoside for refractory acute lymphocytic leukemia with particular reference to T-cell leukemia.
Steuber CP; Levy GJ; Nix WL; Shepherd DA; Starling KA; Fernbach DJ
Med Pediatr Oncol; 1978; 5(1):33-8. PubMed ID: 311413
[TBL] [Abstract][Full Text] [Related]
20. Delayed allergic reactions following intramuscular L-asparaginase.
Spiegel RJ; Echelberger CK; Poplack DG
Med Pediatr Oncol; 1980; 8(2):123-5. PubMed ID: 6932563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
